Scholar Rock Holding (SRRK) EBIT Margin (2019 - 2022)
Scholar Rock Holding (SRRK) recorded quarterly EBIT Margin of 20.89% in Q1 2022, up 97.61% quarter-over-quarter from 873.4% in Q4 2021, and up 55700.0% on a YoY basis from N/an in Q1 2021.
Scholar Rock Holding (SRRK) EBIT Margin (2019 - 2022) Analysis & Trends
Scholar Rock Holding's EBIT Margin history runs 4 years deep, the most recent figure standing at 20.89% for Q1 2022.
- In Q1 2022, EBIT Margin rose 55700.0% year-over-year to 20.89%; the TTM figure through Dec 2022 stood at 404.81% (up 28567.0% YoY), while the FY2022 annual figure was 404.81%, up 28567.0% from the prior year.
- EBIT Margin was 20.89% for Q1 2022 at Scholar Rock Holding, up from 873.4% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 20.89% in Q1 2022 to a low of 873.4% in Q4 2021.
- Historically, EBIT Margin has averaged 489.35% across 4 years, with a median of 499.03% in 2020.
- The sharpest annual moves came in 2020 and 2022: EBIT Margin sank 59668 bps in 2020, then jumped 55700 bps in 2022.
- A 4-year view of EBIT Margin shows it stood at 163.04% in 2019, then plunged by 366 bps to 759.72% in 2020, then dropped by 15 bps to 873.4% in 2021, then surged by 98 bps to 20.89% in 2022.
- The last three EBIT Margin figures came in at 20.89% (Q1 2022), 873.4% (Q4 2021), and 678.57% (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -20.89% |
| Dec 31, 2021 | -873.40% |
| Sep 30, 2021 | -678.57% |
| Jun 30, 2021 | -658.82% |
| Mar 31, 2021 | -577.89% |
| Dec 31, 2020 | -759.72% |
| Sep 30, 2020 | -777.68% |
| Jun 30, 2020 | -499.03% |
| Mar 31, 2020 | -351.77% |
| Dec 31, 2019 | -163.04% |
| Sep 30, 2019 | -358.32% |
| Jun 30, 2019 | -265.65% |
| Mar 31, 2019 | -376.79% |